NICOLE RINICELLA: Open Payments
NPI 1356995138 · WESTLAKE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,025 in 51 payments from 15 companies in 2025. Trend: 2023 $1,591 · 2024 $1,763 · 2025 $1,025
Food & beverage: $1,025
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $300 |
| Janssen Biotech, Inc. | 13 | $212 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| GENZYME CORPORATION | 5 | $106 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $46 |
| Ipsen Biopharmaceuticals, Inc | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| QOL Medical, LLC | 1 | $25 |
| Lilly USA, LLC | 1 | $24 |
| PFIZER INC. | 1 | $21 |
Products named: RINVOQ, TREMFYA, VOQUEZNA, DUPIXENT, XIFAXAN, IQIRVO, LINZESS, ENTYVIO.
Industry payments across OH — which companies pay providers there.
